Common use of Feasibility Study Clause in Contracts

Feasibility Study. 4.1 The Company shall undertake the Feasibility Study from the Commencement Date for the Contract Period, in accordance with the provisions of Schedule 1 and shall use its reasonable endeavours to complete the performance of the Feasibility Study pursuant to the timelines set out in Schedule 1 or as otherwise agreed in writing between the parties. 4.2 The Feasibility Study shall be subject to amendment in accordance with clause 23 as may be agreed in writing by the parties, including but not limited to as a result of collaboration undertaken pursuant to clause 4.6, and each party shall consider in good faith any reasonable amendments proposed by the other party from time to time during the term of this Agreement. 4.3 For the avoidance of doubt, the Approved Costs provided for in Schedule 2 to be paid by the Hospital shall not be increased as a result of any amendments to the Feasibility Study provided under this Agreement. 4.4 The Company shall at all times during the period of this Agreement use all reasonable care and skill in connection with the performance of the Feasibility Study and perform its obligations in accordance with the provisions of clause 16 (Ethics and Compliance). 4.5 It is a condition for receipt of the funding from the Hospital that, in the performance of the Feasibility Study, the Company: 4.5.1 collaborates with clinicians and other members of NHS staff to ensure that the outcome of the Project meets the needs of the NHS; 4.5.2 collaborates with health economists appointed by the Agent at such location and at such times as directed by the Agent. 4.6 A representative from the Company engaged in the Feasibility Study shall meet once per 3 months with the Agent to discuss the progress of the Project. The Company shall be obliged to take into account the opinion of clinical feedback referred to in clause 4.5 in its research development and where reasonable make changes to the focus of the Feasibility Study should the parties agree it. 4.7 In the event of a failure by the Company to comply with its obligations under clauses 3.4, 4.5 and 4.6 above, the Hospital may in its discretion and/or at the direction of the Agent terminate this Agreement and give notice to the Company requiring repayment by the Company of some or all of the Approved Costs paid to the Company up until the date of receipt of such notice.

Feasibility Study. 4.1 The Company shall undertake the Feasibility Study from the Commencement Date for the Contract Period, in accordance with the provisions of Schedule 1 and shall use its reasonable endeavours to complete the performance of the Feasibility Study pursuant to the timelines set out in Schedule 1 or as otherwise agreed in writing between the parties. 4.2 The Feasibility Study shall be subject to amendment in accordance with clause 23 as may be agreed in writing by the parties, including but not limited to as a result of collaboration undertaken pursuant to clause 4.6, and each party shall consider in good faith any reasonable amendments proposed by the other party from time to time during the term of this Agreement. 4.3 For the avoidance of doubt, the Approved Costs provided for in Schedule 2 to be paid by the Hospital shall not be increased as a result of any amendments to the Feasibility Study provided under this Agreement. 4.4 The Company shall at all times during the period of this Agreement use all reasonable care and skill in connection with the performance of the Feasibility Study and perform its obligations in accordance with the provisions of clause 16 (Ethics and Compliance). 4.5 It is a condition for receipt of the funding from the Hospital that, in the performance of the Feasibility Study, the Company: 4.5.1 collaborates with clinicians and other members of NHS staff to ensure that the outcome of the Project meets the needs of the NHS;; and 4.5.2 collaborates with health economists appointed by the Agent Hospital at such location and at such times as directed by the Hospital or the Agent. 4.5.3 agrees to participate in surveys and other activities organised by the Agent for the purpose of collating suitable metrics, updated and published from time to time by the SBRI Healthcare management board, in order to demonstrate impact and the return on investment to funders of the programme for a period not less than 3 years from the Commence Date. 4.6 A representative from the Company engaged in the Feasibility Study shall meet once per 3 months with the Agent to discuss the progress of the Project. The Company shall be obliged to take into account the opinion of clinical feedback referred to in clause 4.5 in its research development and where reasonable make changes to the focus of the Feasibility Study should the parties agree it. 4.7 In the event of a failure by the Company to comply with its obligations under clauses 3.4, 4.5 and 4.6 above, the Hospital may in its discretion and/or at the direction of the Agent terminate this Agreement and give notice to the Company requiring repayment by the Company of some or all of the Approved Costs paid to the Company up until the date of receipt of such notice.

Feasibility Study. 4.1 The Company shall undertake the Feasibility Study from the Commencement Date for the Contract Period, in accordance with the provisions of Schedule 1 and shall use its reasonable endeavours to complete the performance of the Feasibility Study pursuant to the timelines set out in Schedule 1 or as otherwise agreed in writing between the parties. 4.2 The Feasibility Study shall be subject to amendment in accordance with clause 23 as may be agreed in writing by the parties, including but not limited to as a result of collaboration undertaken pursuant to clause 4.6, and each party shall consider in good faith any reasonable amendments proposed by the other party from time to time during the term of this Agreement. 4.3 For the avoidance of doubt, the Approved Costs provided for in Schedule 2 to be paid by the Hospital shall not be increased as a result of any amendments to the Feasibility Study provided under this Agreement. 4.4 The Company shall at all times during the period of this Agreement use all reasonable care and skill in connection with the performance of the Feasibility Study and perform its obligations in accordance with the provisions of clause 16 (Ethics and Compliance). 4.5 It is a condition for receipt of the funding from the Hospital that, in the performance of the Feasibility Study, the Company: 4.5.1 collaborates with clinicians and other members of NHS staff to ensure that the outcome of the Project meets the needs of the NHS; 4.5.2 collaborates with health economists appointed by the Agent Hospital at such location and at such times as directed by the Hospital or the Agent.; and 4.6 A representative from the Company engaged in the Feasibility Study shall meet once per 3 months with the Agent to discuss the progress of the Project. The Company shall be obliged to take into account the opinion of clinical feedback referred to in clause 4.5 in its research development and where reasonable make changes to the focus of the Feasibility Study should the parties agree it. 4.7 In the event of a failure by the Company to comply with its obligations under clauses 3.4, 4.5 and 4.6 above, the Hospital may in its discretion and/or at the direction of the Agent terminate this Agreement and give notice to the Company requiring repayment by the Company of some or all of the Approved Costs paid to the Company up until the date of receipt of such notice.

Feasibility Study. 4.1 The Company shall undertake the Feasibility Study from the Commencement Date for the Contract Period, in accordance with the provisions of Schedule 1 and shall use its reasonable endeavours to complete the performance of the Feasibility Study pursuant to the timelines set out in Schedule 1 or as otherwise agreed in writing between the parties. 4.2 The Feasibility Study shall be subject to amendment in accordance with clause 23 as may be agreed in writing by the parties, including but not limited to as a result of collaboration undertaken pursuant to clause 4.6, and each party shall consider in good faith any reasonable amendments proposed by the other party from time to time during the term of this Agreement. 4.3 For the avoidance of doubt, the Approved Costs provided for in Schedule 2 to be paid by the Hospital shall not be increased as a result of any amendments to the Feasibility Study provided under this Agreement. 4.4 The Company shall at all times during the period of this Agreement use all reasonable care and skill in connection with the performance of the Feasibility Study and perform its obligations in accordance with the provisions of clause 16 (Ethics and Compliance). 4.5 It is a condition for receipt of the funding from the Hospital that, in the performance of the Feasibility Study, the Company: 4.5.1 collaborates with clinicians and other members of NHS staff to ensure that the outcome of the Project meets the needs of the NHS;; and 4.5.2 collaborates with health economists appointed by the Agent Hospital at such location and at such times as directed by the Hospital or the Agent. 4.6 A representative from the Company engaged in the Feasibility Study shall meet once per 3 months with the Agent to discuss the progress of the Project. The Company shall be obliged to take into account the opinion of clinical feedback referred to in clause 4.5 in its research development and where reasonable make changes to the focus of the Feasibility Study should the parties agree it. 4.7 In the event of a failure by the Company to comply with its obligations under clauses 3.4, 4.5 and 4.6 above, the Hospital may in its discretion and/or at the direction of the Agent terminate this Agreement and give notice to the Company requiring repayment by the Company of some or all of the Approved Costs paid to the Company up until the date of receipt of such notice.

Feasibility Study. 4.1 The Company shall undertake the Feasibility Study from the Commencement Date for the Contract Period, in accordance with the provisions of Schedule 1 and shall use its reasonable endeavours to complete the performance of the Feasibility Study pursuant to the timelines set out in Schedule 1 or as otherwise agreed in writing between the parties. 4.2 The Feasibility Study shall be subject to amendment in accordance with clause 23 as may be agreed in writing by the parties, including but not limited to as a result of collaboration undertaken pursuant to clause 4.6, and each party shall consider in good faith any reasonable amendments proposed by the other party from time to time during the term of this Agreement. 4.3 For the avoidance of doubt, the Approved Costs provided for in Schedule 2 to be paid by the Hospital Authority shall not be increased as a result of any amendments to the Feasibility Study provided under this Agreement. 4.4 The Company shall at all times during the period of this Agreement use all reasonable care and skill in connection with the performance of the Feasibility Study and perform its obligations in accordance with the provisions of clause 16 (Ethics and Compliance). 4.5 It is a condition for receipt of the funding from the Hospital Authority that, in the performance of the Feasibility Study, the Company: 4.5.1 collaborates with clinicians and other members of NHS staff to ensure that the outcome of the Project meets the needs of the NHS;; and 4.5.2 collaborates with health economists appointed by the Agent Authority at such location and at such times as directed by the Authority or the Agent. 4.6 A representative from the Company engaged in the Feasibility Study shall meet once per 3 months with the Agent to discuss the progress of the Project. The Company shall be obliged to take into account the opinion of clinical feedback referred to in clause 4.5 in its research development and where reasonable make changes to the focus of the Feasibility Study should the parties agree it. 4.7 In the event of a failure by the Company to comply with its obligations under clauses 3.4, 4.5 and 4.6 above, the Hospital Authority may in its discretion and/or at the direction of the Agent terminate this Agreement and give notice to the Company requiring repayment by the Company of some or all of the Approved Costs paid to the Company up until the date of receipt of such notice.